Profile
Peter L.
J.
Wijngaard is the founder of Corsera Health, Inc. Former jobs include Chairman at Aurinia Pharmaceuticals, Inc. from 2011 to 2013, Independent Director at Hepion Pharmaceuticals, Inc. from 2020 to 2023, Director at Ciclofilin Pharmaceuticals, Inc. from 2014 to 2016, Director-Global Alliance at Hoffmann-La Roche, Inc., Independent Non-Executive Director at Isotechnika Pharma, Inc. from 2011 to 2013, and VP-Innovation Leader Research & Development at The Medicines Company (Schweiz) GmbH.
Education includes a doctorate from the University of Utrecht conferred in 1992.
Former positions of Peter Wijngaard
| Companies | Position | End |
|---|---|---|
| HEPION PHARMACEUTICALS, INC. | Director/Board Member | 2023-12-03 |
The Medicines Company (Schweiz) GmbH | Corporate Officer/Principal | 2019-12-31 |
Ciclofilin Pharmaceuticals, Inc.
Ciclofilin Pharmaceuticals, Inc. Pharmaceuticals: OtherHealth Technology Develops cyclophilin inhibitors for infectious, inflammatory, and degenerative diseases | Director/Board Member | 2016-05-31 |
Isotechnika Pharma, Inc.
Isotechnika Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics | Director/Board Member | 2013-10-22 |
Training of Peter Wijngaard
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Hepion Pharmaceuticals, Inc.
Hepion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drug therapy for treatment of chronic liver diseases | Health Technology |
Ciclofilin Pharmaceuticals, Inc.
Ciclofilin Pharmaceuticals, Inc. Pharmaceuticals: OtherHealth Technology Develops cyclophilin inhibitors for infectious, inflammatory, and degenerative diseases | Health Technology |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Operates as a biotech company that develops pharmaceutical and diagnostic solutions | Health Technology |
University of Utrecht
University of Utrecht Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Isotechnika Pharma, Inc.
Isotechnika Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics | Health Technology |
The Medicines Company (Schweiz) GmbH | |
Aurinia Pharmaceuticals, Inc.
Aurinia Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics | Health Technology |
- Stock Market
- Insiders
- Peter Wijngaard
















